Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipoic acid in multiple sclerosis: a pilot study.
Yadav V, Marracci G, Lovera J, Woodward W, Bogardus K, Marquardt W, Shinto L, Morris C, Bourdette D. Yadav V, et al. Among authors: lovera j. Mult Scler. 2005 Apr;11(2):159-65. doi: 10.1191/1352458505ms1143oa. Mult Scler. 2005. PMID: 15794388 Clinical Trial.
Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, Riddehough A, Li DK, McDougall J, Lovera J, Murchison C, Bourdette D. Yadav V, et al. Among authors: lovera j. Mult Scler Relat Disord. 2016 Sep;9:80-90. doi: 10.1016/j.msard.2016.07.001. Epub 2016 Jul 6. Mult Scler Relat Disord. 2016. PMID: 27645350 Free article. Clinical Trial.
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.
Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA. Bourdette DN, et al. Among authors: lovera j. Mult Scler. 2005 Oct;11(5):552-61. doi: 10.1191/1352458505ms1225oa. Mult Scler. 2005. PMID: 16193893 Clinical Trial.
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.
Lovera JF, Frohman E, Brown TR, Bandari D, Nguyen L, Yadav V, Stuve O, Karman J, Bogardus K, Heimburger G, Cua L, Remingon G, Fowler J, Monahan T, Kilcup S, Courtney Y, McAleenan J, Butler K, Wild K, Whitham R, Bourdette D. Lovera JF, et al. Mult Scler. 2010 Jun;16(6):715-23. doi: 10.1177/1352458510367662. Epub 2010 May 18. Mult Scler. 2010. PMID: 20483885 Clinical Trial.
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
Vandenbark AA, Culbertson NE, Bartholomew RM, Huan J, Agotsch M, LaTocha D, Yadav V, Mass M, Whitham R, Lovera J, Milano J, Theofan G, Chou YK, Offner H, Bourdette DN. Vandenbark AA, et al. Among authors: lovera j. Immunology. 2008 Jan;123(1):66-78. doi: 10.1111/j.1365-2567.2007.02703.x. Epub 2007 Oct 16. Immunology. 2008. PMID: 17944900 Free PMC article. Clinical Trial.
39 results